In Depth 6 Nov 2024 Tuberculosis research: Are we finally close to developing a more effective treatment option? Learn more about the positive advancements that have been made in tuberculosis research in an attempt to find new treatment options. November 6, 2024 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 5 Nov 2024 From consumer health to pure biopharma: Inside Sanofi’s strategic shift Delve into Sanofi’s “play to win” strategy as investments are ramping up after their consumer health division’s divestment. November 5, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Sponsored by KBI Biopharma 5 Nov 2024 Unlocking AAV gene therapy potential: The role of successful characterization Explore the role and challenges of AAV characterization, the significance of capsid filling, and the best methods to enhance gene therapy. November 5, 2024 - 8 minutesmins - By Ute Boronowsky Share WhatsApp Twitter Linkedin Email
News and Trends 4 Nov 2024 Top biotech deals of October 2024 Discover the major biotech partnerships, collaborations and mergers and acquisitions that made headlines in October 2024. November 4, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 1 Nov 2024 Can AI cure Alzheimer’s disease? A couple of weeks back, we took a look at how artificial intelligence (AI) has had a transformative impact on cancer research. Today, we take a look at how AI tools help tackle another formidable challenge of modern biotech, Alzheimer’s disease. “Alzheimer’s is an incredibly complex disease with numerous factors at play. You have the […] November 1, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 1 Nov 2024The immunometabolism landscape To talk about immunometabolism, our guest on the podcast this week is CEO of Sitryx Therapeutics, Iain Kilty. November 1, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
News and Trends 31 Oct 2024 Halloween biotech stories: Unveiling scientists’ worst fears What are scientists scared of? Delve into three biotech sci-fi-inspired scenarios that might make you fear progress. October 31, 2024 - 15 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 31 Oct 2024 Five T cell engager companies you should know about Discover five T cell engager companies that have emerged in recent times, as this class of therapeutics is set to take off. October 31, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 30 Oct 2024 Spatial Transcriptomics: A window into disease The emerging spatial transcriptomics field is letting researchers map out gene expression in tumor and brain samples. How could this change the way we treat disease? October 30, 2024 - 11 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 30 Oct 2024 Could next-generation “switchable” CAR-T cells help improve the safety and efficacy of CAR-T therapies? Discover how next-generation “switchable” CAR-T cells could improve both the safety and efficacy of CAR-T therapies. October 30, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 29 Oct 2024 GPCR therapies: Eight promising biotechs hacking the cell signaling pathway In this article, we take a look at eight biotechs that have acquired funding in recent years to fortify their GPCR-focused pipelines. October 29, 2024 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 25 Oct 2024 How biotech startups are trying to save the oceans with lab-grown fish Find out everything you need to know about lab-grown fish, including the startups trying to save the oceans with their products. October 25, 2024 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email